Analysis of Celgene share price

In the pharmaceutical sector, certain large groups have made their mark on the international scene. This is the case of the Celgene company that we will present to you here. With some information about its activities, you will be able to analyze Celgene shares live from the markets and use these analyzes as part of your investment or investment strategies.  

--- Advertisement ---
Trade the Celgene share!
76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
Analysis of Celgene share price

Elements that can influence the price of this asset:

Analysis N°1

The group's merger or acquisition operations should be closely monitored because of the advantages that this represents for the group's profitability and its positioning on the market.

Analysis N°2

The loans made by the group are also most often a sign of future investment which will undoubtedly pay off quickly. These signals are therefore particularly followed by investors around the world, especially since Celgene benefits from easier access to loans.

Analysis N°3

The average age of the world's population and the increase in life expectancy are important factors for the growth of Celgene's activities and profits, since the elderly are the target of this business.

Analysis N°4

If patents are a strength of this business, we must carefully monitor their expiration and profitability before this expiration which must be sufficient for the investments to be worthwhile.

Analysis N°5

We will also follow increasingly stringent government regulations regarding the drugs and medical products market, which can have a significant impact on Celgene's profits.

Analysis N°6

Finally, we will of course also monitor the release of new drugs by Celgene's competitors, which can harm the group's market shares, in particular when these are more effective than Celgene's products. We will compare these outings with those of the Celgene group in order to have a good visibility on the income possibilities.

--- Advertisement ---
Trade the Celgene share!
76.4% of retail investor accounts lose money when trading CFDs with this provider.

General presentation of Celgene:

The Celgene group is a specialist in the design, development and sale of therapeutic oncology products and the treatment of inflammations of the immune system. However, it is the sale of therapeutic products which generates the majority of the turnover of this company.

Celgene mainly sells its products and licenses in the United States, but also affects Europe and the rest of the world.

 

Knowing Celgene shares competition:

The Celgene group carries out highly targeted activities in the pharmaceutical sector. It is not yet one of the big names in this sector but is fighting against its main competitors in order to gradually gain market share, particularly with regard to the search for cancer treatments. Therefore and to effectively trade the Celgene share, we invite you to discover here which are the largest companies in the world in this area. By studying global pharmaceutical news, you will be better able to assess Celgene's future positioning and the evolution of its share price on the stock market.

The top three places in the world ranking in terms of turnover go to Johnson & Johnson and Pfizer in the United States and to Roche in Switzerland.

GlaxoSmithKline is in fourth place, immediately followed by the Swiss Novartis and the French Sanofi.

The rest of the ranking is occupied by AstraZeneca in the United Kingdom, Abbott and Merck for the United States, Bayer in Germany, Eli Lilly and Bristol Myers Squibb in the United States.

Of course, each new innovation and each news concerning one or other of these pharmaceutical giants is likely to have an influence on the Celgene share price. It is therefore recommended to follow these news and events closely as part of your fundamental analyzes.

 

The strategic alliances set up by the Celgene group:

 

Introduction and listing of Celgene shares :

Celgene's share price has been listed since April 2015 on the Nasdaq Global Select Market. It also includes the calculation of the Nasdaq 100 stock market index.

There is currently little historical data on the listing of this share, whose introduction is too recent. However, over the past year, the stock has been highly stable, with a slight upward trend in July 2015 and a downward correction just after this trend.

 

Stock market data

Celgene shares can be traded on the market through CFDs using the information you have just read here. By using the data from the historical technical analysis of the stock's price and the explanations of the activities carried out by the Celgene Group, you have all the cards in hand to carry out your own analyses and strategies on this stock. But you should also take note of the more general but equally important data about the stock's listing and the group's positioning on the international market. Here are some key data:

 

Benefits of Celgene shares as a stock market asset:

If you are interested in the Celgene share as part of a long-term investment strategy, you should of course be able to anticipate future underlying trends for this asset. For this, the ideal is of course to understand what are the advantages and the shortcomings of this company and thus how it can evolve in the future. Let's start here with a summary of the main strengths of this group.

First, the Celgene group is above all a company based on innovation in many fields. To remain at the forefront of its sector of activity and constantly offer new products and patents, the group has set up a dedicated research and development facility for each of its areas of expertise. The group is thus at the head of a very large number of patents which allows it to stand out from the competition but also to generate additional income.

Investors in the stock market and Celgene shareholders also appreciate the very healthy income stream which shows strong growth in the business. Industry analysts often point this out as one of the greatest strengths of this group.

Celgene also bases its production and research on cutting-edge technology which it does not hesitate to use to its advantage. Thanks to its high-end equipment, the company gains in both productivity and innovation.

Another of its strengths is the work force of Celgene. The group currently has more than 4 employees, most of whom are highly qualified.

Finally, we can of course speak of the very well-conducted acquisition strategy of the Celgene group as being another very important point since it allows the company to position itself more easily internationally and to effectively expand its range of products.

 

Shortcomings of Celgene shares as a stock market asset:

It goes without saying that the Celgene share seems to be an interesting asset with regard to the various points that we have just raised together. However and while Celgene has many strengths, it also has some shortcomings and weaknesses which you should also be aware of. To help you, here is a summary of the biggest weaknesses of this business.

First of all and if the Celgene group benefits from a very large portfolio of products and patents, it remains strongly dependent on a few flagship products. This could thus represent a very significant risk of loss in the event of loss of market share on these products or even of regulatory change as regards them.

Finally, the large size of this company may also prove to be a handicap for its future development. This very large company could indeed encounter certain difficulties in making changes to its overall operation if necessary.

--- Advertisement ---
Trade the Celgene share!
76.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.